umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Quality of life is improved by endoscopic surgery and fluticasone in nasal polyposis with asthma
Department of Clinical Science, Intervention and Technology, Division of Otorhinolaryngology, Karolinska.
Department of Clinical Science, Intervention and Technology, Division of Otorhinolaryngology, Karolinska, Nacka Närsjukhus Proxima AB, Stockholm, Sweden.
Umeå University, Faculty of Social Sciences, Department of Psychology.
Department of Clinical Science, Intervention and Technology, Division of Otorhinolaryngology, Karolinska Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden .
2010 (English)In: Rhinology, ISSN 0300-0729, E-ISSN 1996-8604, Vol. 48, 325-330 p.Article in journal (Refereed) Published
Abstract [en]

The aim was to investigate the health impact of nasal polyposis with asthma and to study effects of endoscopic sinus surgery (ESS), and addition of fluticasone propionate nasal drops (FPND), on health related quality of life (HRQoL).

Methods: Prospective study of 68 patients with nasal polyposis and asthma. Effects were measured with Study 36-Item Short Form (SF-36). A randomized, double-blind, placebo-controlled 14-weeks phase measuring additive effects of FPND 400 μg twice daily (b.i.d.) was included.

Results: HRQoL was significantly decreased in both Physical Component Summary, PCS, and Mental Component Summary, MCS, vs reference population. ESS significantly improved PCS, and MCS after five weeks. We found significant additional benefit of FPND on three domains. The increase in HRQoL with FPND reached reference population levels in all domains, as well as in both PCS and MCS, five weeks after ESS.

 Conclusions: FPND 400 μg b.i.d. can be added to ESS in order to improve, and to reach population levels of, HRQoL already five weeks post-ESS. Physicians should evaluate HRQoL and consider ESS with nasal steroids early in their treatment of these patients.

Place, publisher, year, edition, pages
2010. Vol. 48, 325-330 p.
Keyword [en]
fluticasone propionate nasal drops, nasal polyposis, quality of life, randomized
National Category
Psychology
Research subject
Psychology
Identifiers
URN: urn:nbn:se:umu:diva-36527DOI: 10.4193/Rhino09.142ISI: 000291894500013OAI: oai:DiVA.org:umu-36527DiVA: diva2:354615
Available from: 2010-10-04 Created: 2010-10-04 Last updated: 2017-12-12Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full texthttp://www.rhinologyjournal.com/

Search in DiVA

By author/editor
Nordin, Steven
By organisation
Department of Psychology
In the same journal
Rhinology
Psychology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 45 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf